JAK2 and hyperuricemia: Recent research has demonstrated that hyperuricemia can activate the JAK2/STAT3 signaling pathway in the kidney, thereby contributing to the pathogenesis and progression of hyperuricemia-induced nephropathy (Sun et al. 2023).